The difference is attributed to retatrutides triple receptor mechanism, not its half-life
prescribing decisions are made by affiliated medical providers
Full prescribing details are provided to licensed providers
Certain prescription drugs like Mounjaro and Wegovy are approved by the US Food and Drug Administration (FDA) for weight management, but only after being medically prescribed
Changes in terms of diversity and richness have been associated with conditions, such as obesity, T2D, Parkinsons disease, cardiovascular disease, and IBD
Australia's Chief Medical Officer and the medicines regulator, the Therapeutic Goods Administration, have warned Australians not to take unapproved peptides, saying they were often poorly labelled and presented a health risk